tiprankstipranks
Trending News
More News >
Symbio Pharmaceuticals Limited (JP:4582)
:4582
Japanese Market

Symbio Pharmaceuticals Limited (4582) Financial Statements

Compare
1 Followers

Symbio Pharmaceuticals Limited Financial Overview

Symbio Pharmaceuticals Limited's market cap is currently ¥5.41B. The company's EPS TTM is ¥-24.11; its P/E ratio is -0.96; Symbio Pharmaceuticals Limited is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 2.45B¥ 5.59B¥ 10.01B¥ 8.25B¥ 2.99B
Gross Profit¥ 1.87B¥ 4.41B¥ 7.60B¥ 5.80B¥ 866.85M
Operating Income¥ -3.88B¥ -811.67M¥ 1.96B¥ 1.02B¥ -4.51B
EBITDA¥ -3.78B¥ -714.00M¥ 2.06B¥ 1.11B¥ -4.44B
Net Income¥ -3.83B¥ -1.96B¥ 1.18B¥ 2.03B¥ -4.09B
Balance Sheet
Cash & Short-Term Investments¥ 3.96B¥ 6.52B¥ 6.28B¥ 3.86B¥ 3.85B
Total Assets¥ 4.97B¥ 8.17B¥ 10.43B¥ 8.45B¥ 6.27B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -3.96B¥ -6.52B¥ -6.28B¥ -3.86B¥ -3.85B
Total Liabilities¥ 770.77M¥ 960.33M¥ 1.93B¥ 1.71B¥ 1.62B
Stockholders' Equity¥ 4.20B¥ 7.21B¥ 8.51B¥ 6.75B¥ 4.66B
Cash Flow
Free Cash Flow¥ -3.44B¥ -427.48M¥ 1.57B¥ 76.20M¥ -4.27B
Operating Cash Flow¥ -3.42B¥ -194.69M¥ 1.61B¥ 140.04M¥ -4.12B
Investing Cash Flow¥ -3.96M¥ -376.70M¥ -47.13M¥ -70.85M¥ -160.31M
Financing Cash Flow¥ 708.47M¥ 680.16M¥ 627.99M¥ -71.92M¥ 4.22B
Currency in JPY

Symbio Pharmaceuticals Limited Earnings and Revenue History

Symbio Pharmaceuticals Limited Debt to Assets

Symbio Pharmaceuticals Limited Cash Flow

Symbio Pharmaceuticals Limited Forecast EPS vs Actual EPS